MyFinsight
Home
Blog
About
Contact
Proceeds from issuance of
private placement
$2,943,351
Represents the proceeds
from receivable from...
$2,000,000
Represents the amount of
proceeds received for...
$427,967
Represents the amount of
proceeds from shares to be...
$427,928
Proceeds from offering
costs paid for future...
$42,177
Proceeds for warrants
issued under the...
$564
Represents the amount of
proceeds received for...
$543
Proceeds from warrant
exercises
$500
Cash provided by
(used in) financing...
$5,843,030
Cash, cash
equivalent, restricted...
$2,467,918
Canceled cashflow
$3,375,112
Share-based payment
arrangement, noncash expense
$449,755
Increase (decrease) in
accounts payable and...
$198,759
Increase (decrease) in
due to related...
$71,309
Amount of increase
(decrease) in operating...
$44,700
Represents the amount of
shares to be issued for...
$44,698
Amortization
$12,935
Depreciation
$4,925
Taxes receivable
-$3,037
Fixed asset, disposed
-$2,741
Net cash used in
operating activities
-$3,340,281
Net cash used in
investing activities
-$34,831
Canceled cashflow
$832,859
Net loss
-$4,023,106
Purchase of fixed assets
$34,829
Change in convertible
note receivables
$2
Increase (decrease) in
employee related...
-$76,000
Prepaid expenses
$59,546
Increase (decrease) in
security deposits
-$12,317
Interest receivable
$2,171
Back
Back
Cash Flow
Conexeu Sciences Inc. (CNXU)
Conexeu Sciences Inc. (CNXU)
source: myfinsight.com